IP Verse

Vossius & Partner patent opposition analysis

The comprehensive analysis of Vossius & Partner opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Vossius & Partner

Patent Number	Title	Applicant	Opposition Date	Opposition Company
EP3302635	Syringe Support And Autoinjector	SANOFI AVENTIS DEUTSCHLAND	Jun 3, 2026	SHL MEDICAL
EP3546580	Vectors For Transforming Mycoplasma Hyopneumoniae, Transformed M.Hyopneumoniae Strains, And Use Thereof	HIPRA SCIENTIFIC	Jun 3, 2026	BOEHRINGER INGELHEIM
EP4037735	Drug Delivery Device	AMGEN	Jun 2, 2026	ARROWHOUSE
EP2948654	Catalytic Articles, Systems And Methods For The Oxidation Of Nitric Oxide	BASF	May 20, 2026	UMICORE
EP3407884	Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression Innpm1	MEMORIAL SLOAN KETTERING CANCER CENTER	Apr 9, 2026	ARROWHOUSE
EP4342987	Composition For Cleaving A Target Dna Comprising A Guide Rna Specific For The Target Dna And Cas Protein-Encoding Nucleic Acid Or Cas Protein, And Use Thereof	TOOLGEN INCORPORATED	Feb 4, 2026	VOSSIUS & PARTNER
EP3343726	Vehicle Charging Points Infrastructure Management System	ATOS WORLDGRID SL	Jan 22, 2026	ARROWHOUSE
EP4397760	Composition For Cleaving A Target Dna Comprising A Guide Rna Specific For The Target Dna And Cas Protein-Encoding Nucleic Acid Or Cas Protein, And Use Thereof	TOOLGEN INCORPORATED	Jan 21, 2026	VOSSIUS & PARTNER
EP3363875	Electrically Peelable Adhesive Composition, Adhesive Sheet, And Joined Body	NITTO DENKO	Jan 9, 2026	M INNOVATIVE PROPERTIES
EP3553174	Rna-Guided Human Genome Engineering	PRESIDENT AND FELLOWS OF HARVARD COLLEGE	Dec 30, 2025	VOSSIUS & PARTNER

Top companies who are the clients of Vossius & Partner

Company	Total
STRAWMAN	43
UMICORE	34
VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB	30
VOSSIUS & PARTNER	30
ISCAR	20
SHL MEDICAL	15
THE SHERWIN WILLIAMS	15
CRISPR THERAPEUTICS	12
ARROWHOUSE	11
M INNOVATIVE PROPERTIES	8